Catalyst Wire Dossier Catalyst Wire Dossier

R940343

· Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R940343, covering 2016-09-29 to 2016-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma [Phase 2]

See pricing